Skip to main content
Optovue's blood vessel measurement tech, 3D PAR software cleared by FDA
6/13/2018

The FDA has granted Fremont, Calif.-based Optovue 510(k) clearance for its optical coherence tomography angiography blood vessel measurement technology called Angioanalytics, which facilitates management of progressive blindness-causing diseases. The agency has also cleared the company's 3D projection artifact removal software, which is intended for improving optical coherence tomography angiography image quality.

Full Story: